EFHD2 and metabolic dysfunction-associated steatohepatitis: EFHD2 has been reported to exhibit immunomodulatory and inflammatory regulatory functions in non-alcoholic steatohepatitis (NASH) (72), but its involvement in tumors remains unexplored.